Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or the "Company") now holds two granted US patents covering its core impairment-detection method, after the United States Patent and Trademark Office granted the Company US Patent No. 12,640,164, "Systems and Methods for Detecting Impairment of an Individual," on May 26, 2026. The new grant extends the Company's protection to impairment detection from a single camera on standard, already-deployed hardware, the form factor institutional buyers are most likely to adopt.
The Company has been building this patent estate since 2019, and the same inventive team is named on both grants. Its first patent, US 11,670,323 B2, granted in June 2023, required two or more images of different parts of a person to detect impairment. The second patent granted protects the same underlying method from as few as a single image, with the earlier multi-image and audio-based approaches preserved in the dependent claims.
The significance is both commercial and competitive. A granted method patent gives its owner the right to exclude others from practicing that method. Taken together, the two patents now bracket the deployment spectrum: the first covers multi-camera arrangements, and the currently granted patent extends the same method to a single camera on commodity hardware. The Company therefore holds patented protection over the lightweight deployment that correctional health, defense, transportation and industrial safety buyers actually want, screening that runs on a laptop or tablet already on site, with no new hardware and no installation project. Competitors seeking to offer camera-based impairment screening on standard devices must now contend with the Company's granted claims.
The patented method is the foundation of QScreen's screening platform, which reads physiological, acoustic and behavioral signals to produce a readiness assessment on existing hardware and routes it to a trained supervisor or licensed professional for the decision.
Dr. Rahul Kushwah, Chief Operating Officer of QScreen AI Inc., stated: "We have spent six years building this patent estate, and this is the grant that matters most. Owning the method from a single camera, not just a multi-camera rig, means our protection now covers the exact way institutions want to deploy this, on hardware they already own. We are commercializing from a defended position, and that is a very different place to build from than an idea without a moat."